FDA-Drug2026-05-27Class IPROCESSING DEFECT
MG217 Multi-Symptom Treatment Cream recalled for Staphylococcus aureus contamination
What this means
Wisconsin Pharmacal Company's MG217 Multi-Symptom Treatment Cream (colloidal oatmeal 2%, 6 oz) has been found to contain Staphylococcus aureus bacteria. The contamination was confirmed in lot #1024088 (expiration 11/30/2026). About 690 tubes were distributed nationwide and to the Bahamas.
- Stop using this product if you have it at home.
- Check your MG217 cream for lot #1024088.
- Contact your pharmacist or doctor if you have used this product and have any skin irritation or signs of infection.
The agency's original wording
Hazard
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Intended for
All ages
Illnesses reported
None reported
Sold states
USA Nationwide and Bahamas
Affected count
690 tubes
Manufactured in
N168w22223 Main St, Jackson, WI, United States
Products
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0553-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.